GRACE EMASEALU: Open Payments
NPI 1619279502 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 15 payments from 7 companies in 2025. Trend: 2023 $538 · 2024 $592 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $258 |
| ABBVIE INC. | 6 | $187 |
| Axsome Therapeutics, Inc. | 2 | $146 |
| Neurocrine BioSciences, Inc. | 1 | $81 |
| Alkermes, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Corium, LLC | 1 | $12 |
Products named: COBENFY, VRAYLAR, Auvelity, INGREZZA, ARISTADA, CAPLYTA, Azstarys.
Industry payments across MD — which companies pay providers there.
